JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 06, 2025
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
J.B. Chemicals & Pharmaceuticals has called its 49th AGM for August 6, 2025 at 1:30 PM, to be held via video conferencing. Shareholders will vote on adopting FY25 audited financial statements, confirming the already-paid interim dividend of ₹8.50 per share, and declaring a final dividend of ₹7 per share, taking the total FY25 payout to ₹15.50 per share (record date July 30, 2025; payment on August 13, 2025). The notice also seeks approval to shift the registered office from Mumbai to Ahmedabad, Gujarat, conditional on the Competition Commission of India clearing the proposed amalgamation with Torrent Pharmaceuticals. Other key items include re-appointment of CEO Nikhil Chopra for 5 years at a proposed ₹10 crore per annum salary, re-appointment of Deloitte Haskins & Sells LLP as statutory auditors for another 5-year term, appointment of three independent directors, and waiver of ESOP lock-in on CEO-held shares to facilitate the pending change in control.
The final dividend is a modest incremental payout, but the registered office shift to Gujarat is directly tied to the proposed Torrent Pharma merger and is contingent on CCI approval, making the merger's regulatory clearance the most important catalyst to watch for shareholders. Re-appointment of the CEO and auditors is largely procedural, while the ESOP lock-in waiver clears the way for CEO equity to transfer smoothly once the change in control happens.